封面
市场调查报告书
商品编码
1136945

猴痘治疗市场:各治疗类型(预防,治疗药),各给药途径,各流通管道,各地区- 规模,占有率,展望,机会分析,2022年~2030年

Monkeypox Treatment Market, by Treatment Type (Prophylactic, Therapeutics ), by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场力学

美国卫生与公众服务部已于 2022 年 8 月 4 日宣布猴痘爆发为突发公共卫生事件。因此,对猴痘疫苗和更好治疗方法的需求正在加速。猴痘病患病率的增加以及对猴痘疫苗和新疗法的需求增加预计将推动全球猴痘治疗市场的增长。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间(2022-2030 年)之全球猴痘治疗市场的市场规模和復合年增长率(CAGR %)相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球猴痘治疗市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球猴痘治疗市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球猴痘治疗市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称的说明

第2章 市场展望

  • 报告内容
    • 市场定义和范围
  • 摘要整理
    • 市场概述:各治疗类型
    • 市场概述:各给药途径
    • 市场概述:各销售管道
    • 市场概述:各地区
    • 市场机会蓝图

第3章 猴痘治疗的全球市场见解

  • 促进因素
  • 阻碍因素
  • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的发展情形
  • 产品的上市与核准
  • 法规相关情景
  • 收购,共同研究,伙伴关係方案
  • 流行病学
  • PEST分析
  • 开发平台分析

第4章 猴痘治疗的全球市场:冠状病毒(COVID-19)疫情的影响

  • 经济影响
  • COVID-19流行病学的特征
  • 需求与供给的影响

第5章 猴痘治疗的全球市场:各治疗类型,2017年~2030年

  • 预防
  • 治疗药

第6章 猴痘治疗药的全球市场:各给药途径,2017年~2030年

  • 口服剂
  • 注射剂

第7章 猴痘治疗药的全球市场:各流通管道,2017年~2030年

  • 零售药局
  • 医院内药局
  • 线上药局

第8章 猴痘治疗药的全球市场:各地区,2017年~2030年

  • 北美
  • 美国
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他的南美地区
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东地区
  • GCC
  • 以色列
  • 其他的中东地区
  • 非洲
  • 南非
  • 中非
  • 北非

第9章 企业简介

  • shiga·tekunorojizu
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 财务效能
    • 市场策略
  • kimerikusu公司
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 财务效能
    • 市场策略
  • 拜仁·北欧
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 财务实际成果
    • 市场策略
  • SanofiSA
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 财务效能
    • 市场策略
  • emukyuafama
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 财务效能
    • 市场策略
  • 济南金们医药化工有限公司
    • 公司概要
    • 产品系列
    • 主要的焦点
    • 业绩转变
    • 市场策略

第10章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5199

A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and the monkeypox virus both belong to the same virus family. Monkey pox, however, is not as contagious as smallpox. Additionally, the illness has lesser symptoms and is typically not fatal. The major symptom of Monkeypox is rash that may be located on or near the genitals.

Two outbreaks of a condition resembling the pox that were occurring in groups of monkeys being used for research led to the discovery of monkeypox in 1958. Although, skin-to-skin contact with an infected person can sometimes spread the disease, rodent contact with infected humans accounts for the majority of its transmission. The monkeypox virus has two distinct types, one of which originated in Central Africa and the other in West Africa.

The majority of those who contracted monkeypox in the past either resided and visited specific regions of central or western Africa, or exposed to diseased animals imported from such regions. The disease has been identified in residents of several nations, including the U.S., during the 2022 outbreak.

Market Dynamics

The U.S. Department of Health and Human Services, on August 4 2022 declared monkeypox outbreak as a public health emergency. Due to which there is acceleration in the demand for vaccines and better treatment for monkeypox. Increase in the prevalence of monkeypox disease and increasing demand for vaccines and new treatment for monkeypox is expected to drive growth of the global monkeypox treatment market. For instance, in June 2022, according to the WHO, since 1 January to 22 June 2022, 3413 laboratory confirmed cases and one death have been reported to the WHO from 50 countries/territories in the five WHO Regions. Moreover, 1310 new cases have been reported in eight new countries from regions like African Region, Region of the Americas, Eastern Mediterranean Region and Western Pacific Region.**One death was reported in Nigeria in the second quarter of 2022.

Key features of the study:

  • This report provides an in-depth analysis of the global monkeypox treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global monkeypox treatment market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include SIGA Technologies, Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA, and Emcure Pharma, Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global monkeypox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox treatment market

Detailed Segmentation:

  • Global Monkeypox Treatment Market, By Treatment Type:
    • Prophylactic
    • Vaccines
    • Therapeutics
    • Tecovirimat
    • Brincidofovir
    • Cidofovir
  • Global Monkeypox Treatment Market, By Route Of Administration:
    • Oral
    • Injectable
  • Global Monkeypox Treatment Market, By Distribution Channel:
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • Global Monkeypox Treatment Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • SIGA Technologies
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Chimerix, Inc.
    • Bavarian Nordic
    • Sanofi SA.
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, by Treatment Type
    • Market Snapshot, by Route Of Administration
    • Market Snapshot, by Distribution Channel
    • Market Snapshot, by Region
    • Market Opportunity Map

3. Global Monkeypox Treatment Market Insights

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Launch/Approval
  • Regulatory Scenario
  • Acquisitions, Collaborations & Partnerships Scenario
  • Epidemiology
  • PEST Analysis
  • Pipeline Analysis

4. Global Monkeypox Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact On Supply And Demand

5. Global Monkeypox Treatment Market, By Treatment Type, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Prophylactic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
    • Vaccine
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
    • Tecovirimat
    • Brincidofovir
    • Cidofovir

6. Global Monkeypox Treatment Market, By Route of Administration, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)

7. Global Monkeypox Treatment Market, By Distribution Channel, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030 (US$ Million)

8. Global Monkeypox Treatment Market, By Region, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Region at Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2030, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

9. Company Profiles

  • SIGA Technologies Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chimerix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bavarian Nordic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emcure Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About us